Exercise’s Impact on Cardiometabolic Function: from Extracellular Vesicles to Adipose Tissue Remodeling
Monday, May 13, 2024 from 1:00–2:00 pm ET
Speakers: Steven K. Malin, PhD, FACSM and Pasquale Nigro, PhD
Moderator: Kristin Stanford, PhD, FAHA
Description: Join us for a 2-speaker webinar to learn about the latest published developments in exercise physiology research. We will unravel the impact of acute exercise on fasting and insulin-stimulated extracellular vesicles and will delve into the effects of exercise training on adipose tissue remodeling.
Empowering Adults with Diabetes: Strategies to Support CGM Use in Diabetes Self-Management
Tuesday, May 14, 2024 from 3:00–4:00 pm ET
Speakers: Molly Tanenbaum PhD and Kara Mizokami-Stout, MD
Moderator: Dan DeSalvo, MD
Description: In this one-hour ADA webinar, the speakers will review best practices for strategies to support uptake and maintenance of continuous glucose monitor (CGM) use for self-management in adults with diabetes. Presenters will share five actionable tips for supporting professionals and people with diabetes, as well as host a live Q&A session at the end of the webinar.
Members can earn 1 CE credit by watching the webinar. The session is a part of the Hands On: Tips to Improve Diabetes Care webinar series available exclusively to ADA professional members.
CE Offered: 1 CE credit
Real World Evidence for Clinical Decision Making in Diabetes: Opportunities and Challenges
Friday May 17, 2024 from 12:00–1:00 pm ET
Speakers: Hojin Shin, PhD and Katsiaryna Bykov, PharmD, ScD
Moderator: Dr. Elisabetta Patorno, Past-Chair, ADA Public Health & Epidemiology Interest Group
Description:
Real-world data offer great potential to evaluate the effectiveness and safety of diabetes medications in pharmacoepidemiologic studies, when randomized controlled trials are not available, but come with challenges. This webinar will provide an overview of what is real world evidence (RWE) and the considerations when using or interpreting RWE. Many RWE studies can incur substantial bias not from data limitations or lack of randomization, but from avoidable, bias-inducing study design choices.
Dr. Hojin Shin will provide an overview of what is RWE and its potential role in clinical decision-making. Dr. Katsiaryna Bykov will present major sources of avoidable bias in RWE studies of medication safety and effectiveness and discuss potential solutions and current efforts to improve the quality of RWE studies.
Back to School: Bringing Diabetes Devices into the Classroom
Thursday May 23, 2024 from 4:00–5:00 pm ET
Speakers: Christine March, MD and Crystal Woodward, MPS
Moderators: Stuart Weinzimer, MD and Henry Rodriguez, MD
Description:
In this webinar, we will provide a broad overview of the use of diabetes devices in schools with special attention to continuous glucose monitors. In addition to reviewing the current literature on different perspectives for device use in school, we will review the legal framework to support device use in school and ongoing advocacy efforts at the ADA. Information is geared to help diabetes health care professionals counsel patients and families and communicate with schools on device use in that setting.